This article was written by Follow ONeil Trader is a former stockbroker turned full-time independent investor. He focuses on finding growth and biotech stocks...
This article was written by Follow Excellent academic Finance background and Finance professional with over five years of cumulative experience in Consulting & Audit...
What’s the best-performing sector in 2023? You might say something tech-related. While that is true among large-cap US equities, small and mid-sized companies within...
At a Glance In light of Lyra Therapeutics’ (NASDAQ:LYRA) recent financial and clinical data, investors face a complex investment landscape. On the clinical side,...
After Lucid Group (NASDAQ:LCID) disappointed multiple times with its delivery achievements in FY 2023 and dropped its EV prices by a considerable percentage, the...
The potential Exxon Mobil (XOM) deal to acquire Pioneer Natural Resources (PXD) should make Devon Energy (NYSE:DVN) even more appealing. The independent energy company...
Big Dividends PLUS, Blue Harbinger The BlackRock Health Sciences Term Trust (NYSE:BMEZ) is a closed-end fund (“CEF”) that recently announced a distribution cut, and...